These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7350553)

  • 1. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment.
    de Waard F; Kwa HG; Poortman J
    Oncology; 1980; 37(1):33-6. PubMed ID: 7350553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
    Eliassen AH; Tworoger SS; Hankinson SE
    Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of breast cancer in relation to the use of rauwolfia alkaloids.
    Shapiro S; Parsells JL; Rosenberg L; Kaufman DW; Stolley PD; Schottenfeld D
    Eur J Clin Pharmacol; 1984; 26(2):143-6. PubMed ID: 6723752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rauwolfia and breast cancer: no relation found in long term users age fifty and over.
    Friedman GD
    J Chronic Dis; 1983; 36(5):367-70. PubMed ID: 6853662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rauwolfia derivatives and breast cancer. A case/control study in Olmsted County, Minnesota.
    O'Fallon WM; Labarthe DR; Kurland LT
    Lancet; 1975 Aug; 2(7929):292-6. PubMed ID: 50507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rauwolfia derivatives and breast cancer in hypertensive women.
    Armstrong B; Skegg D; White G; Doll R
    Lancet; 1976 Jul; 2(7975):8-12. PubMed ID: 59126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opinion on rauwolfia therapy].
    Z Allgemeinmed; 1974 Nov; 50(31):1412. PubMed ID: 4464668
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma prolactin levels in patients with breast cancer.
    Rose DP; Pruitt BT
    Cancer; 1981 Dec; 48(12):2687-91. PubMed ID: 7306924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of blood prolactin levels and the risk of subsequent breast cancer.
    Wang DY; De Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Fentiman IS; Hayward JL; Millis RR
    Int J Epidemiol; 1992 Apr; 21(2):214-21. PubMed ID: 1428472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
    Schyve PM; Smithline F; Meltzer HY
    Arch Gen Psychiatry; 1978 Nov; 35(11):1291-1301. PubMed ID: 30426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Rauwolfia derivatives and breast cancer.
    Lancet; 1974 Nov; 2(7892):1315-7. PubMed ID: 4139545
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rauwolfia preparations and breast cancer].
    Levshin VF
    Sov Med; 1977 Sep; (9):145-7. PubMed ID: 929290
    [No Abstract]   [Full Text] [Related]  

  • 13. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women.
    Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Hayward JL; Gravelle IH
    Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1225-31. PubMed ID: 3416905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disordered nocturnal prolactin regulation in women with breast cancer.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4650-4. PubMed ID: 922745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rauwolfia derivatives in relation to breast neoplasms].
    Kimlová I; Mottl V
    Cas Lek Cesk; 1976 Nov; 115(45):1400-1. PubMed ID: 1000551
    [No Abstract]   [Full Text] [Related]  

  • 16. Reserpine and breast cancer in a retirement community.
    Mack TM; Henderson BE; Gerkins VR; Arthur M; Baptista J; Pike MC
    N Engl J Med; 1975 Jun; 292(26):1366-71. PubMed ID: 1138164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma prolactin and its relationship to risk factors in human breast cancer.
    Kwa HG; Cleton F; de Jong-Bakker M; Bulbrook RD; Hayward JL; Wang DY
    Int J Cancer; 1976 Apr; 17(4):441-7. PubMed ID: 945228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of plasma prolactin levels and subsequent risk of breast cancer.
    Kwa HG; Cleton F; Wang DY; Bulbrook RD; Bulstrode JC; Hayward JL; Millis RR; Cuzick J
    Int J Cancer; 1981 Dec; 28(6):673-6. PubMed ID: 7333701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Rauwolfia derivatives and cancer.
    Lancet; 1974 Sep; 2(7882):701-2. PubMed ID: 4142968
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolactin and breast cancer risk.
    Ingram DM; Nottage EM; Roberts AN
    Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.